UBS Group »

Avadel Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.4M 345k 21.55
2025-09-30 $10M 678k 15.27
2025-06-30 $7.7M 875k 8.85
2025-03-31 $10M 1.3M 7.83
2024-12-31 $17M 1.6M 10.51
2024-09-30 $8.0M 607k 13.12
2024-06-30 $3.3M 234k 14.06